Q4 2023 Earnings Call Transcript April 24, 2024 CureVac N.V. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings and ...

CureVac continues to advance its clinical development programs in prophylactic vaccines in collaboration with GSK. All currently tested candidates apply modified mRNA and are based on CureVac’s ...

Pfizer and its Germany partner BioNTech have urged London’s High Court to invalidate competitor Moderna's patents over ...

The Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund have announced the development of the Sputnik V vaccine specifically adapted against Delta ...

In some people, COVID-19 vaccines can lead to heart complications called myocarditis and pericarditis. Myocarditis is the swelling, also called inflammation, of the heart muscle. Pericarditis is the ...

Because the Omicron variant was newly emerging and spreading quickly ... Follow-up data from phase 3 trial of Pfizer-BioNTech COVID-19 vaccine support safety and high efficacy in adolescents 12 ...

A potential juror in former President Donald Trump's hush money trial in New York City spoke to the media shortly after she was excused from the pool, highlighting the "serious" mood inside the ...

Former President Donald Trump is the first U.S. president to face criminal charges in an American courtroom, but most of the country is getting news of the trial secondhand. New York law regarding ...

Donald Trump’s New York hush-money-to-a-porn-star trial has barely begun and, already, his MAGA backers are trying to rig the outcome. On Monday, conservative media personality Clay Travis sent ...

Pfizer and BioNTech would be stopped from raising any invalidity arguments.” Stearns also noted that delaying the case pending the PTAB’s decision should not “prejudice Moderna’s ability to present ...

Vaccines from four different companies are in use across the UK: Pfizer-BioNTech, Moderna ... number of cases were reported during clinical trials. There have also been extremely rare, but ...

Given the huge and growing GLP-1 weight loss market, recent trial data from Viking Therapeutics ... entry into the huge GLP-1 weight loss market, Pfizer makes logical sense on several fronts.